Back to Search Start Over

Modification Tadalafil and Macitentan tablets to aerosol

Authors :
Chrysanthi Karapantzou
Savas Petanidis
George Giannakoulas
Ioannis Kioumis
Georgia Pitsiou
Wolfgang Hohenforst-Schmidt
Chong Bai
Haidong Huang
Dimitris Matthaios
Kosmas Tsakiridis
Christoforos Kosmidis
Chrysa Sardeli
Dimitris Petridis
Paul Zarogoulidis
Source :
Frontiers in Bioscience-Landmark. 27:1
Publication Year :
2022
Publisher :
IMR Press, 2022.

Abstract

Aerosolised drugs have been approved for several diseases such as cystic fibrosis and diabetes. Moreover; there are already drugs for pulmonary hypertension in aerosol form already on the market.Two drugs for pulmonary hypertension (Tadalafil and Macitentan) were milled and transformed from tablets to powder. Three different jet-nebulizers with seven different residual cups were combined. Moreover, we used 3 different ultrasound nebulizers with two different release methods.The drug and residual cup designs produce alone or jointly different MMAD diameters. The three large (10 mls) residual cups with the jet-nebulisers produced the smallest aerosol droplets. Both ultrasound nebulisers are capable of producing optimal size aerosol droplets ≤5 μm mmad.These two drugs can be easily administered as aerosol and an vivo clinical study will prove the safety for the airways.

Details

ISSN :
27686701
Volume :
27
Database :
OpenAIRE
Journal :
Frontiers in Bioscience-Landmark
Accession number :
edsair.doi.dedup.....3adad6d1b8b3a5508fac3a25e6fd5ec7